France
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
15.54%
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
|
2 |
-64.16%
|
Dec. 31, 2023 | USD 2.16 | -2.19% |
|
France |
|
3 |
-462.35%
|
Dec. 31, 2023 | USD 4.64 | -14.23% |
|
France |
|
4 |
-1,042.70%
|
Dec. 31, 2023 | USD 6.91 | 0.46% |
|
France |
|
5 |
-1,803.52%
|
Dec. 31, 2023 | USD 0.96 | -6.39% |
|
France |
The Vaccines company in France with the highest EBT Margin is Sanofi (Paris Stock Exchange: SAN.PA) at 15.54%.
The Vaccines company in France with the lowest EBT Margin is Neovacs S.A. (Paris Stock Exchange: ALNEV.PA) at -1,803.52%.
The top 10 Vaccines companies in France by EBT Margin are Sanofi, Valneva SE, DBV Technologies S.A., OSE Immunotherapeutics SA and Neovacs S.A..
The bottom 10 Vaccines companies in France by EBT Margin are Neovacs S.A., OSE Immunotherapeutics SA, DBV Technologies S.A., Valneva SE and Sanofi.